• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

太平洋地区非传染性疾病的产出损失价值和疾病成本

The value of lost output and cost of illness of noncommunicable diseases in the Pacific.

作者信息

Hou Xiaohui, Anderson Ian, Burton-Mckenzie Ethan-John

机构信息

Health, Nutrition, and Population Global Practice World Bank 1818 H. Street. NW, 20433 Washington DC, United States.

Crawford School of Public Policy, College of Asia & the Pacific, Australian National University, Canberra, Australia.

出版信息

Health Policy Open. 2022 Jul 16;3:100073. doi: 10.1016/j.hpopen.2022.100073. eCollection 2022 Dec.

DOI:10.1016/j.hpopen.2022.100073
PMID:37383583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10297817/
Abstract

BACKGROUND AND OBJECTIVES

The Pacific Island Countries face some of the highest rates of Noncommunicable Diseases (NCDs). This study estimates the economic costs of NCDs for each year from 2015 to 2040, focusing on eleven Pacific Island nations.Data and Methods:Two methods were used to estimate the mortality and morbidity costs using a 'value of lost output' and 'cost of illness' approach respectively.

RESULTS

Five results stand out in terms of projected economic costs of NCD mortality and morbidity analyses in the Pacific: (i) The economic burden of NCDs in the Pacific is greater than expected for middle-income countries; (ii) Although cardiovascular disease is the biggest contributor to the mortality burden in the region, diabetes plays a far greater role in the Pacific countries compared to the global average; (iii) The economic burden of NCDs is increasing with time, especially as incomes rise; (iv)The biggest driver of lost output is the potential loss of labor due to early death from NCDs; and (v) The cost of illness due to diabetes is high across the Pacific countries, with highest among the Polynesian countries.

CONCLUSIONS

NCDs alone can put enormous threat to the small Pacific economies. Targeted interventions to reduce disease prevalence, as outlined in the Pacific NCDs Roadmap, are vital to reduce the long-term costs associated with NCD mortality and morbidity.

摘要

背景与目标

太平洋岛国面临着一些最高的非传染性疾病(NCD)发病率。本研究估算了2015年至2040年每年非传染性疾病的经济成本,重点关注11个太平洋岛国。

数据与方法

分别采用“产出损失价值”和“疾病成本”方法,运用两种方式估算死亡率和发病率成本。

结果

在太平洋地区非传染性疾病死亡率和发病率分析的预计经济成本方面,有五个结果较为突出:(i)太平洋地区非传染性疾病的经济负担高于中等收入国家的预期;(ii)尽管心血管疾病是该地区死亡负担的最大贡献者,但与全球平均水平相比,糖尿病在太平洋国家所起的作用要大得多;(iii)非传染性疾病的经济负担随着时间的推移而增加,尤其是随着收入的增加;(iv)产出损失的最大驱动因素是因非传染性疾病过早死亡导致的劳动力潜在损失;(v)太平洋国家因糖尿病导致的疾病成本很高,在波利尼西亚国家中最高。

结论

仅非传染性疾病就会给太平洋地区的小国经济带来巨大威胁。如《太平洋非传染性疾病路线图》所述,采取有针对性的干预措施以降低疾病患病率,对于降低与非传染性疾病死亡率和发病率相关的长期成本至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/10297817/e1c1ff915e9d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/10297817/b0fb63f5a0ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/10297817/dc16dab79c28/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/10297817/e1c1ff915e9d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/10297817/b0fb63f5a0ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/10297817/dc16dab79c28/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1223/10297817/e1c1ff915e9d/gr3.jpg

相似文献

1
The value of lost output and cost of illness of noncommunicable diseases in the Pacific.太平洋地区非传染性疾病的产出损失价值和疾病成本
Health Policy Open. 2022 Jul 16;3:100073. doi: 10.1016/j.hpopen.2022.100073. eCollection 2022 Dec.
2
The macroeconomic burden of noncommunicable diseases associated with air pollution in China.中国因空气污染导致的非传染性疾病的宏观经济负担。
PLoS One. 2019 Apr 18;14(4):e0215663. doi: 10.1371/journal.pone.0215663. eCollection 2019.
3
Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.1990-2017 年 195 个国家和地区可避免的非传染性疾病过早死亡率趋势:基于人群的研究。
Lancet Glob Health. 2020 Apr;8(4):e511-e523. doi: 10.1016/S2214-109X(20)30035-8.
4
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.NCD 倒计时 2030:全球非传染性疾病死亡率趋势及实现可持续发展目标 3.4 目标进展。
Lancet. 2018 Sep 22;392(10152):1072-1088. doi: 10.1016/S0140-6736(18)31992-5. Epub 2018 Sep 20.
5
Burden of non-communicable diseases from infectious causes in 2017: a modelling study.2017 年由传染性病因导致的非传染性疾病负担:一项建模研究。
Lancet Glob Health. 2020 Dec;8(12):e1489-e1498. doi: 10.1016/S2214-109X(20)30358-2. Epub 2020 Oct 21.
6
Empiricism in non-communicable disease mortality measurement for the Asia-Pacific: lost in translation.亚太地区非传染性疾病死亡率测量中的经验主义:陷入翻译困境。
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003626.
7
The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.中东和北非(MENA)地区非传染性疾病(NCD)研究概况:分析 NCD 负担、研究成果和国际研究合作。
PLoS One. 2020 Apr 27;15(4):e0232077. doi: 10.1371/journal.pone.0232077. eCollection 2020.
8
The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.非传染性疾病对医疗支出和国民收入的全球影响:系统评价。
Eur J Epidemiol. 2015 Apr;30(4):251-77. doi: 10.1007/s10654-014-9984-2. Epub 2015 Jan 18.
9
Trade as a structural driver of dietary risk factors for noncommunicable diseases in the Pacific: an analysis of household income and expenditure survey data.贸易作为太平洋地区非传染性疾病饮食风险因素的结构性驱动因素:家庭收入与支出调查数据分析
Global Health. 2014 Jun 13;10:48. doi: 10.1186/1744-8603-10-48.
10
Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.个体和并发非传染性疾病的卫生系统成本:来自新西兰的公共资助卫生事件分析。
PLoS Med. 2019 Jan 8;16(1):e1002716. doi: 10.1371/journal.pmed.1002716. eCollection 2019 Jan.

引用本文的文献

1
Benefits and challenges: Qualitative exploration of women's experiences during the COVID-19 pandemic in Fiji.益处与挑战:斐济女性在新冠疫情期间经历的质性探索
PLoS One. 2025 Sep 4;20(9):e0331794. doi: 10.1371/journal.pone.0331794. eCollection 2025.
2
Watered down: a cross-case political economy analysis of sugar-sweetened beverage taxes in Vanuatu and Fiji.稀释的政策:瓦努阿图和斐济含糖饮料税的跨案例政治经济学分析。
Health Promot Int. 2024 Dec 1;39(6). doi: 10.1093/heapro/daae142.
3
A scoping review of the unique landscape and challenges associated with dementia in the Western Pacific region.

本文引用的文献

1
The economic burden of COVID-19 in the United States: Estimates and projections under an infection-based herd immunity approach.美国新冠疫情的经济负担:基于感染的群体免疫方法下的估计与预测
J Econ Ageing. 2021 Oct;20:100328. doi: 10.1016/j.jeoa.2021.100328. Epub 2021 May 29.
2
Forecasting the Prevalence of Diabetes Mellitus Using Econometric Models.使用计量经济学模型预测糖尿病的患病率。
Diabetes Ther. 2019 Dec;10(6):2079-2093. doi: 10.1007/s13300-019-00684-1. Epub 2019 Sep 13.
3
The Implications of Aging on the Health Systems of the Pacific Islands: Challenges and Opportunities.
对西太平洋地区痴呆症相关独特情况及挑战的范围综述。
Lancet Reg Health West Pac. 2024 Sep 16;50:101192. doi: 10.1016/j.lanwpc.2024.101192. eCollection 2024 Sep.
4
Health and Nutrition Promotion Programs in Papua New Guinea: A Scoping Review.巴布亚新几内亚的健康与营养促进计划:范围综述。
Nutrients. 2024 Jun 24;16(13):1999. doi: 10.3390/nu16131999.
5
Possibilities and limits of modelling of long-range economic consequences of air pollution - A case study.空气污染长期经济后果建模的可能性与局限性——一项案例研究
Heliyon. 2024 Feb 18;10(4):e26483. doi: 10.1016/j.heliyon.2024.e26483. eCollection 2024 Feb 29.
6
The macroeconomic burden of noncommunicable diseases and mental health conditions in South America.南美洲非传染性疾病和精神健康状况的宏观经济负担。
PLoS One. 2023 Oct 20;18(10):e0293144. doi: 10.1371/journal.pone.0293144. eCollection 2023.
老龄化对太平洋岛屿卫生系统的影响:挑战与机遇
Health Syst Reform. 2017 Jul 3;3(3):191-202. doi: 10.1080/23288604.2017.1342179.
4
Scaling up prevention and control of noncommunicable diseases in the WHO Eastern Mediterranean Region.在世界卫生组织东地中海区域内加强对非传染性疾病的预防和控制。
East Mediterr Health J. 2018 Apr 5;24(1):52-62.
5
Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals.投资于非传染性疾病的预防和管理,以推进可持续发展目标。
Lancet. 2018 May 19;391(10134):2029-2035. doi: 10.1016/S0140-6736(18)30667-6. Epub 2018 Apr 5.
6
Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda.在可持续发展议程下解决低收入和中等收入国家的社会经济不平等和非传染性疾病问题。
Lancet. 2018 May 19;391(10134):2036-2046. doi: 10.1016/S0140-6736(18)30482-3. Epub 2018 Apr 5.
7
Stagnant Stunting Rate despite Rapid Economic Growth-An Analysis of Cross Sectional Survey Data of Undernutrition among Children under Five in Papua New Guinea.尽管经济快速增长,但发育迟缓率仍停滞不前——巴布亚新几内亚五岁以下儿童营养不良横断面调查数据分析
AIMS Public Health. 2016 Jan 21;3(1):25-39. doi: 10.3934/publichealth.2016.1.25. eCollection 2016.
8
Financing for universal health coverage in small island states: evidence from the Fiji Islands.小岛屿国家全民健康覆盖的融资:来自斐济群岛的证据。
BMJ Glob Health. 2017 Mar 21;2(2):e000200. doi: 10.1136/bmjgh-2016-000200. eCollection 2017.
9
Health Impacts of Climate Change in Pacific Island Countries: A Regional Assessment of Vulnerabilities and Adaptation Priorities.气候变化对太平洋岛国的健康影响:脆弱性与适应优先事项的区域评估
Environ Health Perspect. 2016 Nov;124(11):1707-1714. doi: 10.1289/ehp.1509756. Epub 2015 Dec 8.
10
Noncommunicable diseases and risk factors in adult populations of several Pacific Islands: results from the WHO STEPwise approach to surveillance.几个太平洋岛屿成年人群中的非传染性疾病及风险因素:世界卫生组织逐步监测方法的结果
Aust N Z J Public Health. 2015 Aug;39(4):336-43. doi: 10.1111/1753-6405.12398. Epub 2015 Jun 11.